After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
PGEN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Precigen Inc is $405.74M. A total of 1.09 million shares were traded on the day, compared to an average of 1.19M shares.
Insider Activity
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, PGEN has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 38 BUYs and 20 SELLs from insiders. Insiders purchased 2,874,096 shares during that period but sold 359,020.
In the most recent transaction, KIRK RANDAL J bought 96,686 shares of PGEN for 1.41 per share on Dec 28. After the transaction, the Director now owns 1,096,686 company shares. In a previous transaction on Dec 28, KINDLER JEFFREY B sold 96,686 shares at 1.41 per share. PGEN shares that Director owns now total 238,275.
Among the insiders who bought shares, MITCHELL DEAN J acquired of 25,000 shares on Sep 22 at a per-share price of $1.41. This resulted in the Director holding 356,836 shares of PGEN after the transaction. In another insider transaction, Sabzevari Helen sold 76,969 shares at $1.53 per share on Aug 25. Company shares held by the President and CEO now total 1,560,004.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, PGEN has a high of $1.88 and a low of $0.81.
As of this writing, PGEN has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.07 per share and a lower estimate of -$0.08. The company reported an EPS of -$0.08 in the last quarter, which was 20.00% higher than expectations of -$0.1.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PGEN’s latest balance sheet shows that the firm has $108.66M in Cash & Short Term Investments as of fiscal 2021. There were $190.07M in debt and $34.65M in liabilities at the time. Its Book Value Per Share was $0.58, while its Total Shareholder’s Equity was $107.35M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PGEN is Buy with a score of 4.60.
